We’re developing breakthrough cortical implant technology to give vision back to the blind.
Our highly advanced micro-electrode technology allows to implant thousands of electrodes in the brain, each as thin as a single cell. The implant is wirelessly linked with a headset that contains cameras and signal processing. Together, these will enable blind people to re-gain useful vision.
Blindness and severe vision loss are devastating conditions that affect tens of millions of people worldwide, stripping away independence and quality of life.
For many forms of blindness, especially when the retina is affected, there are currently no effective therapies available.
While today’s solutions focus on treating the eye itself, ReVision’s cortical prosthesis represents a breakthrough: bypassing the eye entirely by delivering visual information directly to the brain. Compared to earlier visual prostheses that focused on implanting in the eye, the performance will be at least 10x better - a long awaited breakthrough.
Our mission at ReVision is to transform the lives of people living with blindness by restoring the most vital sense of all; the ability to see.
ReVision has conducted extensive preclinical testing in both mice and non-human primates, demonstrating the long-term safety and feasibility of delivering visual information directly to the brain through cortical electrodes.
These studies have validated our approach of translating a digital camera feed into electrical stimulation patterns distributed across an electrode array in the visual cortex.
The studies demonstrated:
Clear and reproducible activation of visual cortex regions in response to patterned stimulation.
Evidence that stimulation patterns can be differentiated and interpreted by subjects, laying the foundation for perception of visual information.
Confirmation that our approach can be extended from small animal models to primates, supporting the potential for translation into human trials.
ReVision Implant was founded in 2020 by Prof. Peter Janssen and Dr. Frederik Ceyssens with the mission to restore vision through breakthrough neurotechnology. Building on their expertise in the neurophysiology of the visual cortex, brain stimulation, and the microfabrication of flexible implants, they set out to develop a cortical prosthesis that can bypass damaged eyes and deliver visual information directly to the brain.
Since then, ReVision has grown into a multidisciplinary team, uniting neuroscience, engineering, and medical device development with a shared culture of innovation and impact. Our knowledge on extreme miniaturization of medical devices can serve many applications, our main focus is the dire and completely unserved need of treating most forms of blindness.
Frederik co-founded ReVision Implant together with Peter, with great ambition and motivation. Together with the rest of the team he works hands-on on developing the intra-cortical visual prosthesis.
Peter is a neuroscientist with a life-long experience in reseach on the visual system. His great experience in neural implants and work on large primates make him the perfect science partner for ReVision. He's also board member of ReVision.
Maarten is responsible for our work on advanced stimulation patterns and oversees the electronics of the entire device. He has an eye for detail and shows great dedication.
Laurens works on the fabrication and characterization of the Occular implant and especially focuses on implant lifetime engineering.
Jasmine worked as a financial analyst at DHL Express and as European Controller at C&A, as well as a Senior Costing Analyst at DHL International. She then became Financial Planning Manager at DHL International. She's also a member of ReVision's board.
Laura joined our research team to work on the mechanical aspect of the Occular implant, focusing on testing setups and insertion techniques.
Anke obtained her MD degree at KU Leuven, Belgium and gained experience in neurology during her period as resident in Aachen, Germany. She then moved on to obtain a MSc degree in biomedical engineering.
Nils recently joined us, and is working of software and firmware development for the Occular prosthesis.
Ward recently joined ReVision, and is working on wireless power and data communication.
After having completed her PhD that involved testing our implants in rhesus monkeys, Lara is now focusing on translating the results to the clinic.
Johan is serial entrepreneur and has substantial experience in medtech. He was co-founder of Krypton Engineering, and stayed with the company until it was acquired by Metris, then Nikon. Since then he's involved in several ventures including Lab Motion Systems, Elmedix, Xenomatix, Sculpman, Faromatics and Mauhn.
Ruben is Senior partner Emeritus from McKinsey & Company and therefore has extensive experience in strategic management across a wide variety of industrial sectors. He's also founder of Ventures&RV.
Peter is a neuroscientist with a life-long experience in reseach on the visual system. His great experience in neural implants and work on large primates make him the perfect science partner for ReVision. He's also board member of ReVision.
With immense dedication, Olivia studies the use of our implants during in vivo experiments on primates in her capacity as Peter's research assistant.
Michael Kraft leads the ESAT research division Micro- and Nano-systems. He joined ESAT as a full professor in October 2017 and has more than 20 years experience in the design, fabrication and characterization of a wide range of micro- and nanosystems.
Wim Dehaene is a professor at KU Leuven since 2002. Before that time he was working for Alcatel Microelectronics as a senior project director. His main research interests are ultra low power DSP, medical electronics and memories. Besides that he also heads high speed digital circuit research mainly in the domain of digital RF transmitters and digital AD convertors.
Maxime is pursuing a PhD in the design of medical integrated circuits, supervised by Wim Dehaene. He's focused on IC design for the visual prosthesis in the framework of our joint VLAIO project 'StimChip'.
Thomas is a neurosurgeon at the Gasthuisberg University Hospital in Leuven. He's a specialist in brain-machine interfacing and also advises on surgery-related aspects of our developments.
At UPF Barcelona, physicist and neuroscientist prof. Gustavo Deco and his associate Dr. Juan Fuentes are tirelessly working on in silico modelling of neurostimulation in the framework of our joint EIC project.
Dr. Richárd Fiáth leads the team that uses ReVision's stimulator and microelectrodes to study advanced stimulation patterns in the visual cortex of transgenic mice. His home institution is TTK in Budapest, Hungary.
Lucia Wittner received her MSc degree in biology at Eötvös Loránd University, Budapest, Hungary in 1999. She obtained her PhD in neuroscience in 2004 at Semmelweis University Doctoral School, Budapest, Hungary. Currently, she is working in the Institute of Cognitive Neuroscience and Psychology in the Research Center for Natural Sciences, Budapest. Her research interests include synchrony generation in the neocortex and the hippocampus, human epilepsy research and the validation of neural probes.
